Alopecia universalis and Graves’ disease in the setting of immune restoration after highly active antiretroviral therapy
- 1 January 2001
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (1) , 138-140
- https://doi.org/10.1097/00002030-200101050-00026
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Inflammatory Reactions in HIV-1–Infected Persons after Initiation of Highly Active Antiretroviral TherapyAnnals of Internal Medicine, 2000
- Role of Cytotoxic T Cells in Chronic Alopecia AreataJournal of Investigative Dermatology, 2000
- Alopecia Areata is a T-Lymphocyte Mediated Autoimmune Disease: Lesional Human T-Lymphocytes Transfer Alopecia Areata to Human Skin Grafts on SCID MiceJournal of Investigative Dermatology Symposium Proceedings, 1999
- Alopecia Associated with Indinavir TherapyNew England Journal of Medicine, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Vitiligo and Alopecia Areata in Patients With Human Immunodeficiency Virus InfectionSouthern Medical Journal, 1995
- Alopecia universalis in an HIV–positive patient: possible insight into pathogenesisJournal of Cutaneous Pathology, 1993
- Alopecia universalis in a patient seropositive for the human immunodeficiency virusJournal of the American Academy of Dermatology, 1992